Institutional Investors Own a Significant Stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)

Yahoo FinanceDec 11 23:45

Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High?

Zacks Dec 3 22:05

Yun Zhong, PhD, Joins Wedbush Securities as Senior Vice President, Equity Research, Biotechnology

BusinesswireDec 3 21:30

Voyager Therapeutics Analyst Ratings

BenzingaDec 2 19:39 · Ratings

Citi Initiates Voyager Therapeutics(VYGR.US) With Buy Rating, Announces Target Price $12

Futu NewsDec 2 19:32 · Ratings

Express News | Voyager Therapeutics Inc : Citigroup Initiates Coverage With Buy Rating; Price Target $12

BreakingsDec 2 19:22